A Novel De Novo Heterozygous SCN4a Mutation Causing Congenital Myopathy, Myotonia and Multiple Congenital Anomalies

J Neuromuscul Dis. 2019;6(4):467-473. doi: 10.3233/JND-190425.

Abstract

Background: The phenotypic spectrum of the skeletal muscle voltage-gated sodium channel gene (SCN4A) mutations has been expanding dramatically with advancements in genetic testing. Previously only known to cause autosomal dominant myotonia or periodic paralysis, now recessive mutations have been found causing congenital myopathies and congenital myasthenic syndromes.

Case presentation: A 27-year-old woman who was born with Arnold-Chiari malformation, hydrocephalus, high-arched palate, bilateral hip dysplasia, and severe scoliosis presented for evaluation of episodic muscle stiffness and weakness. Electrodiagnostic studies revealed myopathy and widespread myotonia. Muscle histopathology showed marked fiber size variability, type I fiber predominance with minimal scattered necrosis and regeneration which was typical of a congenital myopathy with an additional finding of a lobulated structural pattern in type I fibers. Sequential individual gene testing revealed a novel de novo heterozygous c.2386 C > G, p.Leu796Val missense mutation in the SCN4A gene.

Discussion: To the best of our knowledge, this is the first report of a dominant, heterozygous mutation in SCN4A causing a complex phenotype of congenital myopathy and myotonia with multiple congenital anomalies and unique muscle pathology findings. This case is another addition to the ever expanding phenotype of SCN4A mutations.

Keywords: Arnold-Chiari malformation; SCN4A; bilateral hip dysplasia; congenital myopathy; myotonia; scoliosis.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Female
  • Genetic Testing
  • Heterozygote
  • Humans
  • Muscle, Skeletal / physiopathology
  • Muscular Diseases / genetics*
  • Mutation / genetics*
  • Myotonia Congenita / diagnosis
  • Myotonia Congenita / genetics*
  • NAV1.4 Voltage-Gated Sodium Channel / genetics*
  • Pedigree
  • Phenotype

Substances

  • NAV1.4 Voltage-Gated Sodium Channel
  • SCN4A protein, human